Host-Pathogen interactions of SARS-CoV-2

Markku Varjosalo
Markku Varjosalo

 Var­jos­alo Lab, University of Helsinki, Institute of Biotechnology, Biocenter 3, Viikinkaari 1, FIN-00790 FINLAND

Hospitals involved

Helsinki University Hospital

Project Description

We are currently performing analyses on how the viral proteins interact with the host cell proteome using mass spectrometry. We expect to find new target molecules for therapeutic interventions and also are now testing how the few known drugs used to treat Covid-19 infection alter the pathogen-host molecular interactions. We will perform these analyses also to the possible novel drugs identified by the FIMM screening unit.

Outputs

Publication

Nature

Protocol

Nature